We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

970 hedge funds and large institutions have $46B invested in Thermo Fisher Scientific in 2015 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 380 increasing their positions, 337 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more call options, than puts

Call options by funds: $184M | Put options by funds: $157M

13% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 337

1.15% more ownership

Funds ownership: 88.8%89.95% (+1.1%)

5% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 66

1% more capital invested

Capital invested by funds: $45.8B → $46B (+$256M)

0% less funds holding

Funds holding: 974970 (-4)

1% less funds holding in top 10

Funds holding in top 10: 7069 (-1)

Holders
970
Holders Change
-4
Holders Change %
-0.41%
% of All Funds
27.08%
Holding in Top 10
69
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-1.43%
% of All Funds
1.93%
New
69
Increased
380
Reduced
337
Closed
66
Calls
$184M
Puts
$157M
Net Calls
+$27.2M
Net Calls Change
-$118M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
976
Renaissance Technologies
New York
-$24.4M -188,344 Closed
Two Sigma Investments
977
Two Sigma Investments
New York
-$14.4M -110,981 Closed
TGHSA
978
TPG Group Holdings (SBS) Advisors
Texas
-$13.1M -100,710 Closed
HCM
979
Highbridge Capital Management
New York
-$12.5M -96,462 Closed
SCM
980
Stevens Capital Management
Pennsylvania
-$11.3M -86,998 Closed
TEC
981
Tiger Eye Capital
Tennessee
-$9.1M -70,100 Closed
RSCM
982
Rail-Splitter Capital Management
Illinois
-$7.5M -57,834 Closed
CCM
983
Catapult Capital Management
New York
-$6.49M -50,000 Closed
OI
984
Oakbrook Investments
Illinois
-$6.33M -48,775 Closed
CWA
985
Constellation Wealth Advisors
New York
-$5.45M -41,969 Closed
RPAM
986
Rhenman & Partners Asset Management
Sweden
-$4.8M -37,000 Closed
BMCMI
987
Bryn Mawr Capital Management Inc
Pennsylvania
-$4.63M -35,670 Closed
Voloridge Investment Management
988
Voloridge Investment Management
Florida
-$3.21M -24,751 Closed
HM
989
HealthCor Management
New York
-$3.05M -23,480 Closed
PP
990
PDT Partners
New York
-$3.02M -23,241 Closed
ECML
991
Eagle Capital Management (Louisiana)
Louisiana
-$3.01M -23,188 Closed
LMIM
992
Lockheed Martin Investment Management
Maryland
-$2.73M -21,000 Closed
Walleye Trading
993
Walleye Trading
New York
-$2.52M -19,372 Closed
CI
994
CAZ Investments
Texas
-$1.89M -14,549 Closed
CAM
995
CG Asset Management
New York
-$1.55M -11,955 Closed
Twin Tree Management
996
Twin Tree Management
Texas
-$1.16M -8,913 Closed
JG
997
Jefferies Group
New York
-$967K -7,456 Closed
QIM
998
Quantitative Investment Management
Virginia
-$921K -7,100 Closed
Squarepoint
999
Squarepoint
New York
-$919K -7,081 Closed
TH
1000
Timber Hill
Connecticut
-$825K -6,336 Closed

TMO Hedge Fund Activity: Q3 2015 in Review

970 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2015, worth a combined $46B — up 0.56% from $45.8B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new TMO positions and 66 closed out — a net gain of 3 holders — while 380 added to existing stakes and 337 trimmed.

The largest buyer was Longview Partners, opening a new position worth an estimated $668M. The largest seller was Temasek Holdings, cutting an estimated $309M.

  • 970 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2015, down from 974 in Q2 2015.
  • Funds reported $46B of Thermo Fisher Scientific stock for Q3 2015, up 0.56% quarter-over-quarter.
  • 69 funds opened new Thermo Fisher Scientific positions in Q3 2015 and 66 closed out, a net change of +3 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2015 was Longview Partners, an estimated $668M added.
  • The largest Thermo Fisher Scientific seller in Q3 2015 was Temasek Holdings, an estimated $309M sold.

Based on aggregated 13F filings for Q3 2015.